Oops!
Our apologies, but the article you requested does not exist.
This article not available for purchase.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2004-02-26)
More Articles from Gene Therapy Weekly
- Drug Resistance
Restored caspase expression may resensitize lung cancer cells to chemotherapy - Cancer Therapy
Truncated growth factor signals staunch pancreatic cancer cell proliferation - Clinical Trials
Company wins MEDC contract for dendrimer technology - Coxsackie Virus
Report addresses efficacy of Ampligen in treating myocarditis virus - Drug Delivery
A novel polymeric carrier ushers biomolecular drugs to their targets - Enzymology
Escherichia coli purine nucleoside phosphorylase strengthens gene therapy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
